BMS-986453

· Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BMS-986453, covering 2026-02-13 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma [Phase 1]